Does DMSO Actually Improve Wrinkles? What the Evidence Shows

The dermatology and reconstructive-surgery reviews cited here do not report controlled clinical evidence showing that topical DMSO reduces facial wrinkles or fine lines. They discuss DMSO mainly as a solvent and penetration enhancer, along with research involving scars, wounds, ulcers, scleroderma, and compromised surgical tissue. They provide no validated concentration, formulation, application schedule, treatment duration, or do-it-yourself facial regimen for wrinkles (dermatology review of DMSO’s clinical uses).

That means a wrinkle benefit has not been established by these sources. It does not prove that DMSO could never affect wrinkles under any possible formulation or condition.

The short answer: DMSO is not an evidence-backed wrinkle treatment

None of those facts answers the essential clinical question: Does applying a defined DMSO formulation to aging facial skin produce a meaningful and lasting reduction in wrinkles compared with an appropriate control?

The cited research does not demonstrate such an effect. It provides no wrinkle-specific results for fine lines, wrinkle depth, collagen production, or another validated measure of photoaging.

DMSO for wrinkles: evidence snapshot

• Wrinkle efficacy: Not established
• Tested wrinkle dose: None reported in the cited research
• Repeated facial safety: Not established
• Evidence-supported DIY instructions: None

Concentrations studied for unrelated conditions cannot simply be converted into a wrinkle regimen. A formulation used on a wound, scar, painful joint, surgical flap, or other medical condition was selected for a different tissue state and clinical objective. The fact that both applications involve skin does not make the dose transferable.

Formulation and product quality also matter. DMSO used within a regulated medicine is not equivalent to an industrial solvent or an unregulated consumer topical. Greater purity may reduce one concern—impurities—but would not establish wrinkle efficacy or prove that repeated facial use is safe.

Nor would temporary smoothing settle the question. A topical product can make lines less noticeable through moisturization or other surface effects without producing durable changes in wrinkle depth, collagen, or dermal structure.

What the DMSO skin research actually studied

The cited dermatology literature addresses conditions such as abnormal scars, scleroderma, wounds, ulcers, tissue expansion, threatened surgical tissue, skin-flap perfusion, and drug delivery. Those subjects are biologically and clinically different from ordinary facial aging.

Historical reports that keloids or hypertrophic scars became flatter were not controlled wrinkle trials. These scars result from abnormal tissue formation after injury.

The same distinction applies to healing wounds and surgical flaps. A wound has disrupted tissue and an active repair response. A threatened flap may have impaired blood supply and be at risk of tissue death. An intervention that changes inflammation, blood flow, or survival of compromised tissue does not necessarily remodel wrinkles in otherwise intact skin.

A 2024 narrative review discussed possible vasodilatory, antioxidant, anti-inflammatory, tissue-oxygenation, and membrane-penetrating effects of topical DMSO. Its animal and human evidence focused primarily on wounds and compromised surgical tissue, and its evidence level was described as not gradable (review of topical DMSO in plastic and reconstructive surgery).

Proposed mechanisms can support further research, but they are not cosmetic outcomes. Antioxidant activity in a laboratory, improved flap survival in an animal, or altered blood flow in damaged tissue does not demonstrate that DMSO will reduce crow’s-feet, forehead lines, or other facial wrinkles.

Evidence level	What the cited literature covers	Relevance to wrinkles
Direct human wrinkle trials	No wrinkle results are reported in the cited reviews	Direct efficacy remains unestablished
Unrelated human skin studies	Scars, wounds, ulcers, scleroderma, surgical tissue, and drug delivery	Different tissues, objectives, and outcomes
Animal studies	Flap survival and wound-healing measures	Useful for hypotheses, not proof of visible human wrinkle reduction
Proposed mechanisms	Penetration, vasodilation, antioxidant, and anti-inflammatory effects	Biological plausibility does not establish a cosmetic result
Testimonials	Personal reports of smoother or better-looking skin	Cannot reliably isolate the cause of an apparent change

Testimonials are particularly difficult to interpret. Without a suitable comparison group and objective measurements, it is not possible to determine whether DMSO caused the reported change.

Skin penetration is a property—not proof of rejuvenation

DMSO’s best-supported skin-related role is as a solvent and penetration enhancer. It can affect the stratum corneum, improve the solubility of some substances, and alter how compounds pass into or through the skin.

That property can be useful within a carefully developed medicine. For example, an FDA pharmacology review evaluated DMSO as a penetration enhancer in a specific topical diclofenac formulation intended for knee osteoarthritis. It did not evaluate DMSO as a facial treatment or stand-alone anti-aging ingredient (FDA pharmacology review of the DMSO-containing formulation).

Delivery and efficacy are separate questions. Reaching or crossing the skin does not demonstrate collagen production, reversal of ultraviolet damage, dermal remodeling, or reduced wrinkle depth. A carrier can increase delivery of an effective substance, an ineffective substance, or an unwanted substance.

This makes penetration a double-edged property. These examples are reasons not to experiment with combinations, not suggestions for creating them.

Contamination is another concern. If a nonprescription or industrial-grade product contains impurities or residues, DMSO may facilitate their passage through the skin. A label such as “pure” or “pharmaceutical grade” should not be interpreted as proof that the product treats wrinkles, is suitable near the eyes, or is safe for repeated facial application.

DMSO should also not be confused with MSM or DMAE.

What is known—and unknown—about facial-use safety

Reported topical effects associated with DMSO include irritation, itching, burning or tingling, and dry skin. Because DMSO is absorbed and metabolized, it can also cause a characteristic garlic- or oyster-like odor on the breath.

Broader reports include gastrointestinal, allergic, respiratory, and other systemic reactions. Such reports do not mean every reaction is common or that DMSO was definitively responsible in every case.

A systematic review included 109 human studies involving varied products, routes, doses, medical indications, and study designs. Skin and gastrointestinal reactions were the most frequently reported categories. Reactions were generally dose-related and often transient, but the review did not establish the safety of repeated facial or periocular use. Its conclusion that small doses appeared safe also cannot be converted into a wrinkle recommendation because it defined no wrinkle-treatment dose (systematic review of adverse reactions to DMSO).

Facial application presents questions that general safety findings do not answer.

Question	What is known	Evidence gap
Does it reduce wrinkles?	The cited research does not demonstrate a direct benefit	Controlled studies using objective wrinkle outcomes
What facial concentration is appropriate?	No validated concentration is reported	Facial dose-finding and formulation studies
Is long-term use safe?	Reactions have been reported across varied exposures	Repeated facial-use data over meaningful periods
Is use near the eyes safe?	General safety studies do not establish periocular safety	Periocular tolerability and ocular-exposure evidence
Does product purity solve the problem?	Fewer impurities may reduce one concern	Purity does not establish efficacy or facial safety
Can it be combined with other topicals?	DMSO can increase absorption	Product-specific interaction and tolerability studies

A patch test should not be treated as proof of long-term or systemic safety. The reviewed evidence does not validate a patch-testing or dilution protocol for treating facial wrinkles.

People taking medicines should consult a pharmacist or clinician before considering DMSO because it may increase the absorption—and potentially the effects or side effects—of topical, injected, or oral medicines. People who are pregnant or breastfeeding should also seek clinical guidance rather than relying on an improvised regimen because reliable safety information is insufficient (DMSO interactions, precautions, and product-quality concerns).

Anyone who develops a significant or concerning reaction after exposure should obtain appropriate medical advice rather than continuing to experiment.

Regulatory claims and better-supported ways to address photoaging

The FDA materials and clinical reviews cited here do not support DMSO as an approved wrinkle treatment. An older dermatology review described a 50% intravesical solution administered inside the bladder for interstitial cystitis. That historical medical use does not validate facial application or establish a cosmetic concentration, schedule, or formulation.

Similarly, an FDA review of DMSO as an ingredient or penetration enhancer in another medicine applies only to that product’s formulation, dose, application site, indication, and testing program. It is not a general endorsement of concentrated DMSO for skincare.

The wording of an anti-aging claim also affects how a product is regulated. A product intended only to moisturize skin or conceal lines may be a cosmetic. A product intended to remove wrinkles, increase collagen production, or otherwise affect skin structure or function is generally a drug or, in some cases, a medical device under the FDA’s framework for wrinkle and anti-aging products. Marketing terms such as “rebuilding,” “repairing,” or “rejuvenating” are not clinical evidence.

For photoaging, DMSO compares poorly with better-studied approaches because the cited literature provides neither direct wrinkle results nor an accepted facial regimen. Consistent photoprotection addresses ultraviolet radiation, a central contributor to extrinsic skin aging. Retinoids have substantially stronger support for improving signs of skin aging, although irritation and other tolerability problems can limit their use.

A recent narrative review described retinoids as the most consistently supported skin-aging intervention. It also presented photoprotection, smoking cessation, physical activity, and a balanced low-sugar diet as supportive measures for slowing visible skin aging (review of topical and systemic skin-aging interventions).

That comparison is not a reason to combine DMSO with a retinoid or another active ingredient. Because DMSO can alter penetration, combining products could change exposure rather than simply improve results. A dermatologist can help distinguish lines associated with dryness, cumulative sun exposure, facial movement, or other factors and discuss suitable treatments.

The practical verdict is straightforward: the cited evidence provides neither demonstrated wrinkle reduction nor a defensible facial-use regimen for DMSO. Its capacity to transport substances through skin is a reason for caution, particularly around other topicals and products of uncertain purity. For photoaging, consistent UV protection and a dermatologist-guided discussion of established options such as retinoids have much stronger evidentiary foundations than experimenting with DMSO.